Background illustration for clinical trials search

Hair Loss Clinical Trials

Find clinical trials for hair loss. Search for hair loss clinical trials in different cities and states across the United States.

Filter
Active & Responsive

Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser

for
Hair Loss
Location: New York NY
Sponsor: Lumenis Be Ltd.

Sex: All

Age: 21 - 55

Code: NCT06885112

Recruiting
Active & Responsive

Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy

for
Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Location: Pasadena CA
Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation

Sex: Female

Age: 35 - 55

Code: NCT07810504

Recruiting
Active & Responsive

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

for
Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07487948

Phase 2, Recruiting
Active & Responsive

Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis

for
Scarring Alopecia
Location: Elmsford NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06946550

Recruiting
Active & Responsive

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

for
Alopecia Areata
Location: Portsmouth NH, Boston MA, Verdun, Ottawa, Cutler Bay FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 60

Code: NCT07533006

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

for
Alopecia Areata(AA)
Location: Tampa FL, Columbus OH, Indianapolis IN
Sponsor: HCW Biologics

Sex: All

Age: 18 - 70

Code: NCT07049328

Phase 1, Recruiting
Active & Responsive

Tirzepatide for Treatment of CCCA

for
Central Centrifugal Cicatricial Alopecia (CCCA)
Location: Baltimore MD, Columbia MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07734870

Phase 2, Recruiting
Active & Responsive

Androgenic Alopecia TH07 Clinical Trial

for
Androgenic Alopecia
Location: Vancouver
Sponsor: Triple Hair Inc

Sex: Male

Age: 18 - 49

Code: NCT07435012

Phase 3, Recruiting
Active & Responsive

Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region

for
Alopecia
Location: Kingsport TN
Sponsor: Charles Mays

Sex: All

Age: 18+

Code: NCT07422376

Recruiting
Active & Responsive

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

for
Alopecia Areata, Alopecia Totalis, Alopecia Universalis
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18 - 70+

Code: NCT06747611

Phase 2, Recruiting
Active & Responsive

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT05417308

Early Phase 1, Recruiting

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

for
Alopecia, Chemotherapy-induced Alopecia, Hair Loss,
Location: Urbana IL, Tucson AZ
Sponsor: Cooler Heads Care Inc.

Sex: Female

Age: 21+

Code: NCT05484973

Recruiting

Blood Specimen Collection For Laboratory Assay Research

for
General; Metabolic Disorder, Sexual Dysfunction, Hair Loss,
Location: San Francisco CA
Sponsor: Roman Health Ventures Inc.

Sex: All

Age: 18+

Code: NCT06046651

Recruiting

Autologous Adipose Cells Therapy

for
Hair Loss/Baldness, Wrinkle Appearance, Volume, Fine Lines,
Location: Lewes DE, Newark DE
Sponsor: CERM INC.

Sex: All

Age: 21 - 70+

Code: NCT06869252

Phase 1, Phase 2, Recruiting
New

Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

for
Androgenetic Alopecia
Location: New York NY, Mt. Pleasant SC, Atlanta GA, Smyrna TN,
Sponsor: Pelage Pharmaceuticals, Inc.

Sex: Female

Age: 18 - 65

Code: NCT07907783

Phase 2, Recruiting

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

for
Alopecia Areata
Location: Waltham MA
Sponsor: CorEvitas

Sex: All

Age: 12 - 17

Code: NCT06562270

Recruiting

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

for
Alopecia
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT05213936

Recruiting

Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata

for
Alopecia Areata
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 12 - 18

Code: NCT05414266

Early Phase 1, Recruiting

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

for
Alopecia Areata, Scarring Alopecia
Location: North Attleboro MA, Stevensville MT, Irvine CA
Sponsor: Regeneris Medical

Sex: All

Age: 18 - 70+

Code: NCT03078686

Recruiting

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

for
Alopecia
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 7+

Code: NCT04764357

Recruiting

What hair loss treatments are being studied

Medicines you already know, used in new ways. Topical minoxidil is approved for men and women and sold over the counter; finasteride is approved for men only. Minoxidil as a low dose pill is a blood pressure medicine that some doctors prescribe off label for hair, and trials are comparing it with the topical form, for example in women losing hair during hormone therapy for breast cancer.

New topical anti androgens. Pattern hair loss is driven by DHT, a hormone that shrinks follicles. Clascoterone 5% solution blocks the hormone's effect right in the scalp, and in two Phase 3 trials it met its main goals with side effects similar to placebo. It is not approved yet; the company has said it plans to seek approval in the US and Europe.

Light and laser devices. Several low level laser caps and combs are cleared by the FDA for pattern hair loss, and newer lasers are being tested, including in a study designed for people with darker skin.

Cell based and regenerative procedures. Platelet rich plasma, fat derived cells, and follicle secretome injections are being studied, mostly in early, small trials. None is FDA approved for hair loss.

Hair transplant technology. Studies of robotic systems that help surgeons harvest and place follicles.

Preventing hair loss from cancer treatment. Scalp cooling caps chill the scalp during chemotherapy to protect follicles. The FDA cleared the first one in 2015 for breast cancer and expanded it to all solid tumors in 2017; in the study behind that clearance, about two thirds of women lost less than half of their hair. New trials test portable coolers, other devices, and results in patients of color.

For autoimmune patchy hair loss, the medicines are different; see alopecia areata clinical trials. For scarring hair loss and other types, see our alopecia clinical trials page.

Article preview image

Using minoxidil without the results you hoped for? Read why minoxidil sometimes does not work.

Minoxidil Not Working? Reasons Why & What To Do

Approved, cleared, or experimental: what the labels mean

Does stress cause hair loss?

What is the newest hair loss treatment?

Who can participate in hair loss clinical trials?

How to enroll in a hair loss clinical trial